Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
Clinical trial NCT04534439 · COMPLETED
Trial details
- NCT number
- NCT04534439
- Sponsor
- Aptabio Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2021-07-26
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.